Utility of determining autoantibodies to M-type phospholipase A2 receptor in diagnosing primary membranous nephropathy: An ideal setting
Main Authors: | R Ramachandran, V Kumar, N Singh, M Kataruka, M Rathi, H S Kohli, V Jha, K L Gupta |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2017-01-01
|
Series: | Indian Journal of Nephrology |
Online Access: | http://www.indianjnephrol.org/article.asp?issn=0971-4065;year=2017;volume=27;issue=5;spage=413;epage=415;aulast=Ramachandran |
Similar Items
-
Autoantibodies against phospholipase A2 receptor in Korean patients with membranous nephropathy.
by: Yun Jung Oh, et al.
Published: (2013-01-01) -
The role of Anti-phospholipase A2 Receptor Autoantibody as a biomarker of Idiopathic Membranous Nephropathy
by: Rodrigo Manuel Brás Batata
Published: (2021) -
A New Chemiluminescence Immunoassay for Phospholipase A2 Receptor 1 Autoantibodies Allows Early Identification of Autoantibody Recurrence in Patients With Membranous Nephropathy
by: Elion Hoxha, et al.
Published: (2021-04-01) -
CD19 Targeted Low-Dose Rituximab Is Effective in the Management of Refractory Phospholipase A2 Receptor Antibody-Associated Membranous Nephropathy
by: Raja Ramachandran, et al.
Published: (2017-01-01) -
Autoantibodies in the Diagnosis, Monitoring, and Treatment of Membranous Nephropathy
by: Vladimir Tesar, et al.
Published: (2021-03-01)